Anti-Chitinase-3-Like-1 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody recognizing human Chitinase-3-Like-1 (CHI3L1/YKL-40), a secreted glycoprotein involved in inflammation, tissue remodeling, and Th2 responses.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-
UniProt
P36222
Size
100ug
Cat. #
RP1Chitinase3Like1

In stock

SKU
RP-Chitinase3Like1

Options

As low as: $130.00

Target Overview

Chitinase-3-like protein 1 (CHI3L1, UniProt P36222), commonly known as YKL-40 or cartilage glycoprotein-39 (CGP-39), is a 383-amino acid secreted glycoprotein that belongs to the glycosyl hydrolase 18 family. Despite structural homology to active chitinases, CHI3L1 lacks enzymatic activity and instead functions as a carbohydrate-binding lectin with preference for chitin-containing substrates. The protein is secreted into the extracellular space and plays established roles in tissue remodeling, cellular stress responses, and inflammatory signaling. CHI3L1 contributes to T-helper cell type 2 (Th2) inflammatory responses and mediates IL-13-induced inflammation by regulating allergen sensitization, dendritic cell accumulation, and M2 macrophage differentiation. The protein also activates AKT1 signaling in colonic epithelial cells, leading to IL-8 production and facilitating bacterial invasion into intestinal mucosa. In lung tissue, CHI3L1 regulates macrophage-mediated bacterial killing and modulates hyperoxia-induced epithelial injury and apoptosis. Its expression is elevated in numerous pathological contexts, making it a biomarker of interest in inflammatory, fibrotic, and neurodegenerative diseases.

Background

CHI3L1 was originally identified as a 39 kDa synovial protein abundant in arthritic joints, where it is secreted by chondrocytes, synoviocytes, and infiltrating macrophages. The YKL-40 designation derives from the N-terminal amino acids (tyrosine, lysine, leucine) and its apparent molecular weight. Beyond rheumatic diseases, CHI3L1 has emerged as a biomarker in diverse conditions including asthma, COPD, liver fibrosis, cardiovascular disease, and cancer, where elevated circulating levels often correlate with disease severity and poor prognosis. Recent proteomic studies have implicated CHI3L1 in Alzheimer's disease pathogenesis, with cerebrospinal fluid and plasma levels serving as indicators of neuroinflammation and glial activation. Sha et al. (2026) reviewed the mechanistic role of YKL-40 in Alzheimer's disease pathology and its potential as a therapeutic target, highlighting its association with microglial activation and neurodegeneration. Single-cell spatial omics analyses of synovial tissue in rheumatoid and psoriatic arthritis have revealed distinct CHI3L1 expression patterns among disease-specific macrophage subsets, underscoring its role in localized inflammatory responses. The lectin activity of CHI3L1 appears to mediate many of its biological effects through binding to cell-surface receptors and extracellular matrix components, triggering signaling cascades that promote cell survival, migration, and cytokine production. In bacterial infections, CHI3L1 exhibits dual functions: it enhances epithelial barrier penetration by enteric pathogens while simultaneously augmenting innate immune responses in lung macrophages. This context-dependent activity reflects the protein's broader role in balancing tissue protection with controlled inflammation. Triple Point Biologics offers five rabbit polyclonal antibodies raised against the aminoterminus of mature CHI3L1, providing researchers with validated reagents for Western blot, immunohistochemistry, and immunofluorescence applications in human samples. These antibodies have supported investigations into CHI3L1 expression patterns across inflammatory, metabolic, and neurodegenerative disease models.

References

  1. Sha Y et al (2026) The role of YKL-40 in Alzheimer's disease pathology and drug targeting. PeerJ. PubMed · 10.7717/peerj.21361
  2. Khmelevskaya A et al (2026) Single-Cell and Spatial Omics Uncover Disease-Specific Synovial Landscapes in Rheumatoid and Psoriatic Arthritis. J Rheumatol. PubMed · 10.3899/jrheum.2026-0375
  3. Donmez TB (2026) From prediction to mechanism: Explainable AI uncovers plasma and CSF proteomic signatures of Alzheimer's disease. J Proteomics. PubMed · 10.1016/j.jprot.2026.105698
  4. Eckerström M et al (2026) Cognitive outcome in relation to cerebrospinal fluid markers of neuronal and glial cell damage: A prospective study of tick-borne encephalitis. Ticks Tick Borne Dis. PubMed · 10.1016/j.ttbdis.2026.102673

Additional Specifications

Gene Symbol CHI3L1
UniProt ID P36222
Host Species Rabbit
Species Reactivity Validated- Human
Potential-
Pack Size 100ug
Immunogen (Aminoterminus of mature Chitinase-3-like-1)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 22-70.
Immunogen (Between the aminoterminus and the heparin binding site)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 22-72.
Immunogen (Heparin binding site)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 171-230.
Immunogen (Area between the heparin binding site and carboxyterminus.)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 333-383.
Immunogen (Carboxyterminus of human chitinase-3-like-1)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 331-383.
Alternate Names CHI3L1, YKL-40, Cartilage glycoprotein 39, CGP-39, GP-39, hCGP-39, 39 kDa synovial protein, Chitinase-3-like protein 1

Frequently Asked Questions

What molecular weight should I expect for CHI3L1/YKL-40 on Western blot?

CHI3L1 migrates at approximately 40 kDa on reducing SDS-PAGE, though the calculated molecular weight from the 383-amino acid sequence is 42.6 kDa. The protein is glycosylated at multiple sites, which can shift the apparent mass slightly depending on post-translational modification status and cell type. Some laboratories report bands between 38-42 kDa. The YKL-40 designation itself refers to the tyrosine-lysine-leucine N-terminal residues and 40 kDa mass. If you observe higher molecular weight species, consider that CHI3L1 can form oligomers under non-reducing conditions or in certain buffer systems.

Does this antibody work for mouse or rat CHI3L1 detection?

This antibody is validated for human CHI3L1. Cross-reactivity with mouse or rat orthologs has not been experimentally confirmed. Human CHI3L1 shares approximately 60-65% sequence identity with mouse Chi3l1 (also called BRP-39) and rat orthologs, which limits reliable prediction of cross-reactivity. If you require detection in rodent samples, we recommend confirming reactivity in your system with appropriate positive controls or considering antibodies raised specifically against the mouse or rat sequences. Species-specific validation data is available upon request.

What dilution should I start with for Western blot of CHI3L1?

Start at 1:1000 dilution in blocking buffer for Western blot, as recommended in our validation data. This concentration has been optimized for detection of CHI3L1 from human cell lysates and conditioned media. Because CHI3L1 is a secreted protein, expect stronger signal in conditioned medium or serum samples compared to whole-cell lysates. If background is high, titrate up to 1:2000; if signal is weak with low-abundance samples, try 1:500. Incubation overnight at 4°C often improves sensitivity compared to one-hour room-temperature binding.

Is CHI3L1 an intracellular or secreted protein for sample preparation?

CHI3L1 is a secreted glycoprotein, so it is most abundant in conditioned culture medium, serum, plasma, or extracellular tissue fractions. For Western blot, concentrate conditioned medium 10-20 fold using centrifugal filters (10 kDa cutoff) to improve detection. Whole-cell lysates will contain primarily intracellular precursor and Golgi-resident forms. If analyzing tissue, consider preparing separate cytosolic and secreted/extracellular fractions. Avoid repeated freeze-thaw cycles of serum or medium samples, as CHI3L1 stability can decrease. For IHC, extracellular and perinuclear Golgi staining patterns are typical.

What are good positive and negative controls for CHI3L1 antibody validation?

Human macrophages, particularly M2-polarized macrophages, are strong positive controls as they secrete high levels of CHI3L1. Chondrocytes, synovial fibroblasts, and certain cancer cell lines (e.g., U87 glioblastoma, MDA-MB-231 breast cancer) also express CHI3L1 constitutively or upon IL-13 or IL-6 stimulation. For negative controls, use lysates from CHI3L1 knockout cells if available, or unstimulated fibroblasts and epithelial lines with low basal expression. Including recombinant human CHI3L1 protein as a lane control confirms the expected 40 kDa band. Peptide competition assays can further verify specificity.

Does CHI3L1 have splice variants or isoforms I should be aware of?

The primary CHI3L1 transcript encodes a single 383-amino acid protein with a 21-residue signal peptide. Alternative splicing has not been widely reported for CHI3L1, and most studies focus on the full-length secreted form. However, differential glycosylation across tissues and disease states can produce minor mobility shifts on gels. In some inflammatory contexts, proteolytic cleavage products or degradation fragments may appear as lower molecular weight bands. If you observe multiple bands, verify identity by peptide competition or mass spectrometry. The antibody targets a broad epitope region, so it should detect the predominant full-length form.

Can I use this CHI3L1 antibody for immunohistochemistry or immunofluorescence?

Yes, Triple Point Biologics antibodies are validated for Western blot; IHC and immunofluorescence validation is in progress. For IHC on formalin-fixed paraffin-embedded tissue, antigen retrieval is typically required; citrate buffer (pH 6.0) heat-induced epitope retrieval is a standard starting point. Expect extracellular and cytoplasmic perinuclear staining in CHI3L1-expressing cells such as macrophages, chondrocytes, and activated fibroblasts. Start with a 1:100-1:200 dilution for IHC and titrate based on signal intensity and background. For IF, 1:50-1:100 is a common range. Include isotype controls to assess non-specific binding.

How should I store the CHI3L1 antibody and what is the shelf life?

Store the antibody at -20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. The antibody is supplied in a stabilized buffer and remains stable for at least 12 months when stored properly at -20°C. For frequent use, keep a working aliquot at 4°C for up to one month; add 0.02-0.05% sodium azide as preservative if desired, though avoid azide if using the antibody for applications involving HRP-conjugated secondaries. Do not store diluted antibody for extended periods; prepare fresh working dilutions in blocking buffer for each experiment.

Western blot validation for RP-Chitinase3Like1 — 5 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

Chitinase-3-Like-1: Aminoterminus of mature Chitinase-3-like-1 — WB validation
WB · Panel 1 Chitinase-3-Like-1: Aminoterminus of mature Chitinase-3-like-1
Chitinase-3-Like-1: Between the aminoterminus and the heparin binding site — WB validation
WB · Panel 2 Chitinase-3-Like-1: Between the aminoterminus and the heparin binding site
Chitinase-3-Like-1: Heparin binding site — WB validation
WB · Panel 3 Chitinase-3-Like-1: Heparin binding site
Chitinase-3-Like-1: Area between the heparin binding site and carboxyterminus — WB validation
WB · Panel 4 Chitinase-3-Like-1: Area between the heparin binding site and carboxyterminus
Chitinase-3-Like-1: Carboxyterminus of human chitinase-3-like-1 — WB validation
WB · Panel 5 Chitinase-3-Like-1: Carboxyterminus of human chitinase-3-like-1

Custom validation studies available on request — contact us.

Also known as:

  • CHI3L1
  • YKL-40
  • Cartilage glycoprotein 39
  • CGP-39
  • GP-39
  • hCGP-39
  • 39 kDa synovial protein
  • Chitinase-3-like protein 1
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →